PRESS RELEASE. FASENRA® (benralizumab) Approved in the US for Self-administration in a New Pre-filled Auto-injector, the FASENRA Pen™ FASENRA is now the only respiratory biologic that offers the choice of administration at home or in a doctor’s office with eight-week maintenance dosing

FASENRA 360 provides injection support* from a nurse, as well as other FASENRA support services. Join today or call 1-833-360-HELP (4357) Monday–Friday, 8 AM to 6 PM ET. * Information from our nurses does not replace the advice or training from your physician or other healthcare providers.

2024年8月28日 · Fasenra (benralizumab) is commonly used to treat the following conditions. A certain type of severe asthma, ... 10 mg/0.5 mL injection, prefilled syringe; 30 mg/mL injection, prefilled syringe and ...

2024年10月3日 · Fasenra injection may be used to treat severe eosinophilic asthma in adults and children aged 6 years and older or eosinophilic granulomatosis with polyangiitis (EGPA) in adults. Fasenra's mechanism of action (MOA) involves specifically targeting eosinophils, which are white blood cells associated with inflammation found in the airways of ...

The FASENRA Savings Program is for commercially insured patients to cover patient out-of-pocket costs for FASENRA and its administration, up to $13,000 per calendar year. If you need help paying for FASENRA, AstraZeneca may be able to help. You can get more information on FASENRA affordability programs by calling 1-833-360-HELP (4357).

Patients/caregivers may administer with FASENRA Pen after proper training in subcutaneous injection technique and after the healthcare professional determines it is appropriate. In patients aged 6 to 11 years weighing 35 kg or more, FASENRA Pen should only be given by a caregiver or healthcare provider. 1

The recommended dosage of FASENRA is 30 mg (one injection) administered subcutaneously every 4 weeks for the first . 3 doses, and then every 8 weeks thereafter. Pediatric Patients 6 to 11 Years of Age The recommended dosage of FASENRA for pediatric patients 6 to 11 years of age is based on body weight as provided in . Table 1. Table 1.

The FASENRA prefilled syringe is an injection administered under the skin (subcutaneously) by a healthcare provider. The FASENRA Pen is an injection administered under the skin (subcutaneously) by the patient, caregiver or healthcare provider. Do not try to inject the FASENRA Pen until you have been trained by your healthcare provider.

Fasenra® (benralizumab) Pen (auto-injector) ... Fasenra (benralizumab) is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody indicated as add-on maintenance treatment of patients with severe asthma aged 6 years and older, and with an eosinophilic phenotype.

2019年10月4日 · GRECO is a Phase III multicentre, open‑label, 28-week trial designed to assess patient‑ or caregiver‑reported functionality, performance and reliability of a pre-filled auto-injector device with a fixed 30mg dose of Fasenra administered subcutaneously (SC) every four weeks in clinic and in an at‑home setting in 120 adults with severe ...